• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Mid Europa buys MediGroup from Blue Sea Capital

  • Nicole Tovstiga
  • Nicole Tovstiga
  • 05 March 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Mid Europa Partners has acquired a majority stake in Blue Sea Capital portfolio company MediGroup, a Serbia-based private healthcare provider.

Zagreb-based private equity firm Blue Sea established the group in 2013 and will retain a 45% stake in the company. Mid Europa meanwhile acquired a 55% stake.

Mid Europa intends to leverage its experience growing healthcare providers in the CEE region, such as its portfolio companies LuxMed in Poland and Regina Maria in Romania, to help accelerate the development of MediGroup.

MediGroup

  • DEAL:

    SBO

  • LOCATION:

    Belgrade

  • SECTOR:

    Healthcare providers

  • FOUNDED:

    2013

  • VENDOR:

    Blue Sea Capital

Meanwhile, Blue Sea's continued ownership is expected to ensure continued access to local resources in Serbia.

The transaction is subject to competition clearance and is expected to close in in the second half of 2018.

Mid Europa is currently investing from its latest fund, Mid Europa IV, which held a final close on €800m in August 2014. The vehicle has a €650m pre-allocated co-investment programme, allowing its 25 LPs to invest directly alongside the fund, according to Unquote Data.

Previous funding
Blue Sea established Serbian healthcare platform MediGroup in 2013. It has since been on the acquisition trail to consolidate healthcare providers in the region, seeking to build a network of health centres in Belgrade, as well as in other Serbian cities.

Blue Sea first consolidated health centre Dr Ristic and gynaecological hospital Jevremova. It then acquired Serbian outpatient service Dom Zdravlja Jedro from Delta Generali Insurance in June 2013, ahead of the official launch of MediGroup.

Company
Established in 2013 and headquartered in Belgrade, MediGroup is a private healthcare provider in Serbia with 13 facilities across the country's major cities, providing inpatient, outpatient, laboratory, IVF, ophthalmology and cosmetology services.

People
Mid Europa – Matthew Strassberg (co-managing partner); Csanad Daniel (principal partner).
Blue Sea Capital – Vuk Vukovic (partner); Sasa Galic (managing partner).
MediGroup – Dejan Pešić (CEO).

Advisers
Equity – Sidley Austin, ZSP (legal); EY (corporate due diligence); PwC (financial due diligence).
Vendor – Allen & Overy (legal); Van Campen Liem (legal); BDK (financial due diligence); KPMG (corporate due diligence). 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • CEE
  • Healthcare
  • Secondary buyout
  • Serbia
  • Poland
  • Romania
  • Mid Europa Partners
  • EY (Ernst & Young)
  • PwC
  • KPMG

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013